In the recent study of Farcas et al. it has been shown, that in patients with coronary artery disease (CAD) and without myocardial infarction (MI) leptin represents a potential mechanism of unfavourable cardiac remodelling: it was associated with left ventricular enddiastolic dimension and left ventricular relative wall thickness12. The gene discussed is LEP; the disease is coronary artery disorder.